{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:00:12Z","timestamp":1794344412679,"version":"4.9.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T00:00:00Z","timestamp":1605916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016670","name":"Region \u00d6sterg\u00f6tland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010805","name":"Forskningsr\u00e5det i Syd\u00f6stra Sverige","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010805","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.metabol.2020.154439","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T20:46:53Z","timestamp":1606250813000},"page":"154439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6364-8758","authenticated-orcid":false,"given":"Julia","family":"Blomdahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2928-4188","authenticated-orcid":false,"given":"Patrik","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5590-8601","authenticated-orcid":false,"given":"Mattias","family":"Ekstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7614-739X","authenticated-orcid":false,"given":"Stergios","family":"Kechagias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2020.154439_bb0005","doi-asserted-by":"crossref","unstructured":"EASL\u2013EASD\u2013EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Journal of hepatology. 2016;64(6):1388\u2013402. doi:https:\/\/doi.org\/10.1016\/j.jhep.2015.11.004.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"10.1016\/j.metabol.2020.154439_bb0010","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption\u2014II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction."},{"key":"10.1016\/j.metabol.2020.154439_bb0015","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT Alcohol Consumption Questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test","volume":"158","author":"Bush","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.metabol.2020.154439_bb0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drugalcdep.2017.04.026","article-title":"Assessing phosphatidylethanol (PEth) levels reflecting different drinking habits in comparison to the alcohol use disorders identification test - C (AUDIT-C)","volume":"178","author":"Schrock","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.metabol.2020.154439_bb0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/dta.278","article-title":"Phosphatidylethanol in blood (B-PEth): a marker for alcohol use and abuse","volume":"3","author":"Isaksson","year":"2011","journal-title":"Drug Test Anal"},{"issue":"11","key":"10.1016\/j.metabol.2020.154439_bb0030","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/acer.12851","article-title":"Ethanol metabolites: their role in the assessment of alcohol intake","volume":"39","author":"Wurst","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.metabol.2020.154439_bb0035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1369-1600.2009.00185.x","article-title":"Phosphatidylethanol: normalization during detoxification, gender aspects and correlation with other biomarkers and self-reports","volume":"15","author":"Wurst","year":"2010","journal-title":"Addict Biol"},{"issue":"4","key":"10.1016\/j.metabol.2020.154439_bb0040","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2337\/dc14-1556","article-title":"The effect of alcohol consumption on insulin sensitivity and glycemic status: a systematic review and meta-analysis of intervention studies","volume":"38","author":"Schrieks","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2020.154439_bb0045","article-title":"Established and emerging factors affecting the progression of nonalcoholic fatty liver disease","volume":"154183","author":"Kechagias","year":"2020","journal-title":"Metabolism."},{"issue":"3","key":"10.1016\/j.metabol.2020.154439_bb0050","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/gutjnl-2013-305718","article-title":"Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals","volume":"63","author":"Sookoian","year":"2014","journal-title":"Gut."},{"key":"10.1016\/j.metabol.2020.154439_bb0055","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.2633","article-title":"Alcohol consumption and risk of fatty liver disease: a meta-analysis","volume":"4","author":"Cao","year":"2016","journal-title":"PeerJ."},{"issue":"4","key":"10.1016\/j.metabol.2020.154439_bb0060","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jhep.2014.11.025","article-title":"Roles of alcohol consumption in fatty liver: a longitudinal study","volume":"62","author":"Moriya","year":"2015","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.metabol.2020.154439_bb0065","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1053\/j.gastro.2020.05.054","article-title":"ADH1B *2 is associated with reduced severity of nonalcoholic fatty liver disease in adults, independent of alcohol consumption","volume":"159","author":"Vilar-Gomez","year":"2020","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.metabol.2020.154439_bb0070","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/liv.12754","article-title":"Light alcohol consumption plays a protective role against non-alcoholic fatty liver disease in Japanese men with metabolic syndrome","volume":"35","author":"Sogabe","year":"2015","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.metabol.2020.154439_bb0075","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3748\/wjg.v18.i2.156","article-title":"Protective effect of alcohol consumption for fatty liver but not metabolic syndrome","volume":"18","author":"Hamaguchi","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2020.154439_bb0080","doi-asserted-by":"crossref","first-page":"278785","DOI":"10.1155\/2015\/278785","article-title":"Presence of fatty liver and the relationship between alcohol consumption and markers of inflammation","volume":"2015","author":"Kachele","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"3","key":"10.1016\/j.metabol.2020.154439_bb0085","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/jgh.12786","article-title":"Modest alcohol consumption reduces the incidence of fatty liver in men: a population-based large-scale cohort study","volume":"30","author":"Hashimoto","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.metabol.2020.154439_bb0090","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/ajg.2009.361","article-title":"Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population","volume":"104","author":"Gunji","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.metabol.2020.154439_bb0095","doi-asserted-by":"crossref","unstructured":"Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology (Baltimore, Md). 2017;65(5):1557\u201365. doi:https:\/\/doi.org\/10.1002\/hep.29085.","DOI":"10.1002\/hep.29085"},{"key":"10.1016\/j.metabol.2020.154439_bb0100","doi-asserted-by":"crossref","first-page":"154005","DOI":"10.1016\/j.metabol.2019.154005","article-title":"Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: a proof of concept study","volume":"101","author":"Perakakis","year":"2019","journal-title":"Metabolism."},{"key":"10.1016\/j.metabol.2020.154439_bb0105","article-title":"Use of imaging techniques for non-invasive assessment in the diagnosis and staging of non-alcoholic fatty liver disease","volume":"154355","author":"Miele","year":"2020","journal-title":"Metabolism."}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049520303036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049520303036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:25:45Z","timestamp":1758428745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049520303036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":21,"alternative-id":["S0026049520303036"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154439","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154439"}}